Muthiah Vaduganathan, MD, FACC

Muthiah Vaduganathan

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Relypsa(MODEST), Amgen(SIGNIFICANT), Baxter Healthcare(SIGNIFICANT), Cytokinetics(MODEST), Bayer AG(SIGNIFICANT), AstraZeneca(SIGNIFICANT), Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Lexicon Pharmaceuticals(MODEST), Sanofi-Aventis(SIGNIFICANT) SPEAKER'S BUREAU: Roche Diagnostics(MODEST), Novartis Corporation(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Amgen(SIGNIFICANT), AstraZeneca(SIGNIFICANT), Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Galmed(MODEST), Novartis Corporation(SIGNIFICANT), Impulse Dynamics(MODEST), Sanofi-Aventis(SIGNIFICANT), Occlutech(MODEST)

View Full Disclosure